Vaccine-Med @Vaccine-Med: "Dear Investors, Here is your monthly..."

Smart Portfolio

Dear Investors, Here is your monthly update for November 2025 ✨ November was a volatile month for markets, with major indexes swinging sharply before recovering most losses. Concerns over a potential AI bubble, shifting expectations around U.S. rate cuts, and weakness in crypto contributed to the turbulence. Beyond AI, Healthcare rebounded strongly, interest-rate expectations shifted following Fed commentary, and commodities diverged as oil fell while gold and silver rose. Crypto markets struggled, with both Bitcoin and Ethereum posting double-digit declines. 💭 Find out more about what happened in November with eToro's Smart Portfolios Monthly summary here: etoro.turtl.co/story/etoros-investment-office-performance-report-nov25 **New on eToro! Recurring Copy lets you automatically add a fixed amount each month to Smart Portfolios, helping you grow your investments steadily and effortlessly!** Performance Stats: @Vaccine-Med-> November: 1.07% , QTD: 2.01% YTD: 1.23% Benchmark (SGH - S&P Global 1200 Health Care Sector GICS Level 1 Index) -> November: 8.17% , QTD: 11.38% YTD: 13.82% Best Performer: $MRK (Merck & Co.) 21.92% Worst Performer: $ARCT (Arcturus Therapeutics Holdings Inc) -31.90% Portfolio Indicated Dividend Yield: 0.92% Some of the assets inside the @Vaccine-Med Smart Portfolio are: $BAVA.CO (Bavarian Nordic A/S) , $DVAX (Dynavax Technologies Corp) , $CVAC , $NVAX (Novavax Inc) , $PSNL (Personalis Inc) , $MRVI (Maravai LifeSciences Holdings Inc.) , $VIR (Vir Biotechnology Inc) , $VLA.PA (Valneva SE) , $EBS (Emergent BioSolutions Inc) , $VXRT (Vaxart Inc) ❓ Check out the portfolio fact sheet by clicking the following link: bullaware.com/factsheet/Vaccine-Med This Smart Portfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Please remember past performance is not indicative of any future performance.